ADMA Biologics Inc.

NASDAQ: ADMA · Real-Time Price · USD
16.70
-0.27 (-1.59%)
At close: Aug 15, 2025, 11:44 AM

ADMA Biologics Revenue

ADMA Biologics reported an annual revenue of $426.45M, reflecting a 65.15% growth. For the quarter ending June 30, 2025, ADMA Biologics generated $121.98M in revenue.
Revenue (ttm)
426.45M
Revenue Growth
65.15%
Price / Sales Ratio
9.37
Revenue / Employee
622.56K
Employees
685
Market Cap
3.99B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.